← Back to headlines
Serina Therapeutics Reports GAAP EPS of -$1.91 and Revenue of $0.13M
Serina Therapeutics announced its latest financial results, reporting a GAAP Earnings Per Share (EPS) of -$1.91 and total revenue of $0.13 million.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
